Unichem Laboratories Ltd announced that it has received approval from the US Food and Drug Administration to market its generic version of labetalol hydrochloride tablets, which are used to treat high blood pressure.
Over 90% of the domestic drug market in 2022—which has grown to be worth Rs 1.67 trillion—was dominated by locally produced medications. The industry is now talking about breaking into the top five by 2047.
Corporate mismanagement, alleged attempts to influence a judge, and illegal manufacturing of life-saving drugs – a publicly traded Andhra Pradesh firm has become the epicentre of the many ills that continue to plague the Indian pharmaceutical sector.
The Comptroller and Auditor General of India highlighted several lapses in the procurement and supply chain of drugs under the Central Government Health Scheme in its audit report tabled, which resulted in a drug shortage at wellness centres.
Revenue from the pharmaceutical segment increased to Rs 883.6 crore, up from 409.7 crore in the first quarter of last year. This included earnings from the settlement of claims received by Natco Pharma (Canada) Inc under a settlement agreement.
Known as a pioneer in recombinant human albumin-based products, Albumedix Ltd. recently disclosed that it has signed a binding agreement to be acquired by Sartorius, a world leader in laboratory and bioprocessing technologies for the biopharmaceutical sector.
TROPION-Lung02 phase Ib trial preliminary
results showed promising clinical activity and
a tolerable safety profile in patients with
previously untreated or pretreated, advanced
or metastatic non-small cell lung cancer
(NSCLC) without actionable genomic alterations.
If you don’t already have an account click the button below to create your account.Create New Account